Richard J Berman Cryoport, Inc. (CYRX) insider trading activity

CYRX Quotes by TradingView

Richard J Berman is Director of Cryoport, Inc.. Currently has a direct ownership of 112,845 shares of CYRX, which is worth approximately $886,961. The most recent transaction as insider was on May 17, 2024, when has been sold 12,845 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 113K
0% 3M change
4.38% 12M change
Total Value Held $886,961

RICHARD J BERMAN Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 17 2024
BUY
Grant, award, or other acquisition
-
12,845 Added 10.22%
112,845 Common Stock
May 15 2024
SELL
Open market or private sale
$108,688 $13.41 p/Share
8,105 Reduced 7.5%
100,000 Common Stock
May 12 2023
BUY
Grant, award, or other acquisition
-
8,105 Added 6.97%
108,105 Common Stock
May 11 2023
SELL
Open market or private sale
$154,936 $21.51 p/Share
7,203 Reduced 6.72%
100,000 Common Stock
Aug 16 2022
SELL
Open market or private sale
$116,579 $43.05 p/Share
2,708 Reduced 2.46%
107,203 Common Stock
Apr 30 2022
BUY
Exercise of conversion of derivative security
-
2,708 Added 2.4%
109,911 Common Stock
Apr 29 2022
BUY
Grant, award, or other acquisition
-
7,203 Added 6.3%
107,203 Common Stock
Sep 15 2021
SELL
Open market or private sale
$1,594,500 $63.78 p/Share
25,000 Reduced 20.0%
100,000 Common Stock
Sep 13 2021
BUY
Exercise of conversion of derivative security
$404,750 $16.19 p/Share
25,000 Added 16.67%
125,000 Common Stock
Apr 07 2021
BUY
Exercise of conversion of derivative security
$328,466 $11.82 p/Share
27,789 Added 21.75%
100,000 Common Stock
Mar 24 2021
BUY
Exercise of conversion of derivative security
$373,242 $7.3 p/Share
51,129 Added 41.45%
72,211 Common Stock
Feb 25 2021
BUY
Exercise of conversion of derivative security
$98,664 $4.68 p/Share
21,082 Added 50.0%
21,082 Common Stock
Nov 11 2020
SELL
Open market or private sale
$1,111,000 $55.55 p/Share
20,000 Reduced 100.0%
0 Common Stock
Nov 11 2020
BUY
Exercise of conversion of derivative security
$76,400 $3.82 p/Share
20,000 Added 50.0%
20,000 Common Stock

Also insider at

OTRK
Ontrak, Inc. Healthcare
COMS
COMSovereign Holding Corp. Communication Services
Director
TRIQ
TRAQIQ, INC. Technology
Director
BIVI
BIOVIE INC. Healthcare
Director
CNTX
Context Therapeutics Inc. Healthcare
Director
CELU
Celularity Inc Healthcare
Director
RJB

Richard J Berman

Director
Brentwood, TN

Track Institutional and Insider Activities on CYRX

Follow Cryoport, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CYRX shares.

Notify only if

Insider Trading

Get notified when an Cryoport, Inc. insider buys or sells CYRX shares.

Notify only if

News

Receive news related to Cryoport, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CYRX